Evidence-Based Comparison: Wegovy vs Mounjaro Facts
What's Best Wegovy or Mounjaro: Understanding Prescription Weight Loss Mechanisms
When evaluating what's best Wegovy or Mounjaro for prescription weight loss, the fundamental difference lies in their mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, reducing appetite and promoting satiety after smaller meals. Mounjaro (tirzepatide) represents a newer dual-agonist approach, targeting both GLP-1 and GIP receptors simultaneously, potentially offering enhanced blood sugar control alongside weight management benefits.
Both prescription-only medicines work by influencing brain appetite centres and slowing gastric emptying, but their receptor targeting differs significantly. Your prescriber can assess which mechanism suits your individual health profile, considering factors like diabetes status, cardiovascular risk, and previous treatment responses. At EverydayMeds, our clinical team reviews each assessment to ensure the most appropriate prescription weight loss option for your circumstances.
Pricing Comparison: What's Best Wegovy or Mounjaro Value
Cost considerations often influence decisions about what's best Wegovy or Mounjaro for prescription weight loss treatment. Wegovy follows a structured dose escalation from £79.99 for the 0.25mg starter dose (using code FIRST40), progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. Our Intro Duo bundle provides your first two doses (0.25mg and 0.5mg) for £169.99, ensuring seamless transition into treatment.
Mounjaro pricing reflects its newer dual-agonist technology, though both treatments remain accessible through EverydayMeds' regulated prescription service. Bundle options like our Ultimate Stability Trio (three 2.4mg Wegovy pens for £649.99) provide three months of maintenance supply with convenient single-delivery logistics. Returning customers benefit from code DOSE25 at checkout, whilst our GPhC-registered pharmacy (#9012878) ensures all orders meet stringent cold-chain delivery standards.
Clinical Evidence: What's Best Wegovy or Mounjaro Research Data
Clinical trial evidence helps inform decisions about what's best Wegovy or Mounjaro for individual patients. In the landmark STEP trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, with the STEP 3 intensive behavioural therapy study showing around 16% weight reduction (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events amongst participants using semaglutide.
Mounjaro's SURMOUNT clinical programme shows similar impressive results, though direct head-to-head comparisons remain limited due to different trial designs and patient populations. Both treatments require ongoing commitment, with STEP 1 extension data indicating patients regained approximately two-thirds of weight lost within one year of stopping treatment, emphasising that weight management represents a long-term healthcare commitment rather than a short-term intervention.
How Wegovy Works: Understanding GLP-1 Prescription Weight Loss
Understanding how Wegovy functions helps clarify what's best Wegovy or Mounjaro for your prescription weight loss journey. As a GLP-1 receptor agonist, Wegovy mimics incretin hormones naturally produced in your intestines after eating, sending satiety signals to brain appetite centres and reducing food cravings. The once-weekly FlexTouch pen delivers semaglutide subcutaneously, providing sustained appetite suppression between doses whilst slowing gastric emptying to prolong feelings of fullness. This mechanism works synergistically with dietary modifications and increased physical activity, creating a comprehensive approach to weight management that addresses both physiological and behavioural factors contributing to weight gain.
EverydayMeds Ordering Process: What's Best Wegovy or Mounjaro Access
Accessing either option when deciding what's best Wegovy or Mounjaro begins with EverydayMeds' streamlined 3-minute clinical assessment, covering your medical history, current medications, and weight management goals. Our qualified prescribers review applications within 3 working days (express 24-hour service available), ensuring appropriate prescription-only medicine selection based on your individual circumstances and NICE TA875 guidance. Once approved, next-day temperature-controlled delivery ensures your chosen treatment arrives in optimal condition, with comprehensive injection guidance and ongoing clinical support included throughout your prescription weight loss programme.
Storage and Practical Considerations: What's Best Wegovy or Mounjaro Convenience
Practical differences may influence what's best Wegovy or Mounjaro for your lifestyle and travel requirements. Wegovy offers superior storage flexibility, remaining stable at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both require initial refrigerated storage at 2-8°C, but Wegovy's extended ambient stability provides advantages for frequent travellers or those with limited refrigeration access. The FlexTouch pen design offers intuitive dose administration, whilst the structured dose escalation schedule (0.25mg through to 2.4mg maintenance) allows gradual tolerance development and side effect minimisation.
Eligibility and Safety Profile: What's Best Wegovy or Mounjaro Suitability
Determining what's best Wegovy or Mounjaro involves assessing individual eligibility criteria and contraindications for prescription weight loss treatment. Both medications are licensed for adults with BMI ≥30, or BMI ≥27 with weight-related comorbidities such as hypertension, dyslipidaemia, or obstructive sleep apnoea. Wegovy's established safety profile from extensive STEP trial data provides confidence for prescribers, though both treatments require careful assessment of gastrointestinal tolerance, thyroid disease history, and concurrent medication interactions.
Your EverydayMeds prescriber evaluates medical history factors including previous bariatric surgery, eating disorders, diabetic retinopathy, and pancreatitis risk when determining prescription weight loss suitability. Neither treatment should be used during pregnancy or breastfeeding, and both require ongoing monitoring for potential side effects including nausea, vomiting, and rare but serious complications such as acute pancreatitis.
Long-term Success Strategy: What's Best Wegovy or Mounjaro Maintenance
Long-term success with either option requires understanding that prescription weight loss represents an ongoing commitment rather than a temporary intervention. Clinical data demonstrates that maintaining weight loss benefits requires continued treatment, with structured lifestyle modifications providing synergistic effects. Whether you choose Wegovy or Mounjaro, establishing sustainable dietary patterns and exercise routines during the initial dose escalation period maximises long-term outcomes and reduces reliance solely on medication for weight maintenance.
EverydayMeds supports your prescription weight loss journey with repeat prescription services, ensuring uninterrupted treatment supply and ongoing clinical oversight. Our Ultimate Stability Trio provides three months of 2.4mg Wegovy maintenance doses for £649.99, whilst our clinical team remains available for dosing adjustments, side effect management, and treatment optimisation throughout your weight management programme.
Start Your Prescription Weight Loss Journey Today
Both Wegovy and Mounjaro are available from EverydayMeds — your prescriber can help determine which is right for you based on your individual circumstances and treatment goals. Our 3-minute online assessment begins the prescription process, with new customers using code FIRST40 and returning customers applying DOSE25 at checkout for optimised pricing. Next-day cold-chain delivery ensures your chosen prescription-only medicine arrives safely, with comprehensive support available throughout your weight management journey. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment and take the first step towards evidence-based prescription weight loss treatment. Your path to sustainable weight management starts with expert prescriber guidance and MHRA-licensed medication access.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
